AbCellera acquires TetraGenetics

By The Science Advisory Board staff writers

September 13, 2021 -- Artificial intelligence-powered biotech and drug discovery platform AbCellera has acquired biotechnology firm TetraGenetics.

TetraGenetics offers a platform that generates recombinant human ion channels and transmembrane proteins such as G protein-coupled receptors. The acquisition will allow AbCellera to integrate TetraGenetics' biotechnology into its drug discovery efforts, it said.

Financial details of the acquisition were not disclosed.


Copyright © 2021 scienceboard.net
 


Email Address:

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.